Clinical milestones keep shifting. The financial model hasn't moved with them.
You're managing grants, equity, and loans at once, with no unified reporting structure.
Regulatory scenarios are hard to quantify- until they show up in your runway.
Your investor reporting covers the science. The financial case is still missing.
Your finance setup was built for a pre-clinical team. The next stage has different requirements.
